Mebicar, tablets 300 mg 20 pcs

The drug belongs to the anxiolytic, stress-protective, nootropic drugs.

It improves myocardial tissue oxygen supply; normalizes the disturbed electrolyte balance of blood, the content of potassium ions in plasma, erythrocytes and myocardial cells; promotes increased protein synthesis and increased energy resources of the cell.

It regulates disturbed night sleep without a direct sleeping effect. It does not have a cholinolytic and muscle relaxant effect, does not affect the coordination of movements. It facilitates or relieves nicotine withdrawal.

Pharmacokinetics

Extracted completely in the urine within 24 hours.

Indications

Irritability, Anxiety, Smoking cessation, Cardialgia (heart pain), Psycho-emotional tension, Neurosis

• Neurotic disorders (irritability, emotional lability, anxiety, anxious-depressive, phobic, panic disorder), developed as a result of debilitating psycho-emotional, neuropsychiatric and physical exertion;
• .in complex therapy for the treatment of patients with cardialgia, coronary heart disease and rehabilitation after myocardial infarction;
• to reduce craving for smokingneurosis-like conditions in patients with alcoholism, to reduce pathological cravings for alcohol and psychoactive substances;
• to improve the tolerance of neuroleptics and tranquilizers.

.

Active ingredient

Tetramethyltetraazabicyclooctandione

Composition

Active substances:

mebicar 0.3 g

Supplementary substances:

povidone (polyvinylpyrrolidone high molecular weight) – 0.0015 g;

calcium stearate – 0.0015 g